Jul 13, 2016 - The short term earnings outlook for these stocks have been building momentum recently, so don't miss out!
Jul 31, 2015 - Dr. Reddy's Laboratories Ltd. (NYSE:RDY) Q1 2016 Earnings Conference Call July 30, 2015 9:00 AM ET Executives Kedar Upadhye – Head of Global Generics Finance & Investor Relations Saumen Chakrabort
Aug 28, 2015 - AxoGen (AXGN) was a big mover last session, with shares rising over 13% on the day.
Sep 11, 2015 - AbbVie (ABBV) gained ninth FDA approval for Humira for the treatment of patients suffering from moderate-to-severe hidradenitis suppurativa.
Sep 15, 2015 - AbbVie (ABBV) is looking to get Imbruvica approved in the U.S. for the front-line treatment of patients suffering from chronic lymphocytic leukemia.
Sep 21, 2015 - BioMarin (BMRN) announced that it has entered into a settlement agreement with Dr. Reddy's (RDY) to resolve the patent litigation related to Kuvan.
Jul 14, 2016 - Teva (TEVA) provided its preliminary outlook for 2016-2019 and expects the Actavis Generics acquisition to go through anytime soon.
Jul 27, 2016 - Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q2 2016 Earnings Conference Call July 26, 2016 09:00 ET Executives Kedar Upadhye - Investor Relations Saumen Chakraborty - Chief Financial Officer Abhijit M
Apr 20, 2017 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
May 15, 2017 - Dr. Reddy's Laboratories Ltd. (RDY) reported fourth-quarter fiscal 2017 earnings per American Depositary Share (ADS) of 29 cents, down from 7 cents in the year-ago quarter.